Loading patent…
AssigneeAvestha Gengraine Technologies Pvt. Ltd.
InventorsVilloo Morawala Patell, Dhruvdev Vyas
Estimating the term…
The invention relates to extracts from Terminalia plant species that are capable of being used in methods for managing diseases such as cardiovascular disease, diabetes, degenerative neurological diseases, cancer, age related diseases like amyloidosis, acute pancreatitis, arthritis, atherosclerosis, cancer, heart diseases, inflammatory bowel disease, myocardial infarction, senile dementia, retinal degeneration and senile cataract; owing to the extracts antioxidation potential. The invention also relates to extracts from Terminalia plant species that are capable of being used in methods for managing various infectious diseases. More particularly, the invention relates to certain extracts from Terminalia arjuna, their uses as antimicrobial and antioxidants agents for the treatment of certain diseases heart disease, diabetes, degenerative neurological diseases, cancer, age related disease like amyloidosis, acute pancreatitis, arthritis, atherosclerosis, cancer, cardiovascular disease, inflammatory bowel disease, myocardial infarction, senile dementia, retinal degeneration and senile cataract in mammals, particularly humans, processes for obtaining them and delivery formats therefore
A method for treating a disease selected from the group comprising cardiovascular disease, diabetes, degenerative neurological diseases, cancer, age related diseases like amyloidosis, acute pancreatitis, arthritis, atherosclerosis, cancer, heart disease, inflammatory bowel disease, myocardial infarction, senile dementia, retinal degeneration and senile cataract in a mammal, which comprises administering to the said mammal an effective non-toxic amount of at least an extract from Terminalia arjuna selected from those as defined in Tables 1-24.
A method for treating infectious diseases in a mammal, which comprises administering to the said mammal an effective non-toxic amount of at least an extract from Terminalia arjuna selected from those as defined in Tables 1-24.
A pharmaceutical formulation for use in the treatment of a disease selected from the group consisting of cardiovascular disease, diabetes, degenerative neurological diseases, cancer, age related diseases like amyloidosis, acute pancreatitis, arthritis, atherosclerosis, cancer, heart disease, inflammatory bowel disease, myocardial infarction, senile dementia, retinal degeneration and senile cataract, comprising at least one extract isolated from Terminalia arjuna, and selected from those listed in Tables 1-24 in admixture with a pharmaceutically acceptable carrier.
A pharmaceutical formulation for use in the treatment of any infectious disease, comprising at least one extract isolated from Terminalia arjuna, and selected from those listed in Tables 1-24 in admixture with a pharmaceutically acceptable carrier.
A method for the preparation of a pharmaceutical formulation comprising bringing into association at least an extract of the invention, and a pharmaceutically acceptable carrier therefore.
An extract from Terminalia arjuna selected from the group consisting of the extracts having the HPLC and/or MS characteristics shown in Tables 1-24.
A comestible comprising at least an extract from Terminalia arjuna selected from the group consisting of the extracts having the HPLC and/or MS characteristics shown in Tables 1-24.
Use of an extract selected from the group consisting of the extracts having the HPLC and/or MS characteristics shown in Tables 1-24 for the preparation of a medicament for the treatment of disease selected from the group consisting of cardiovascular disease, diabetes, degenerative neurological diseases, cancer, age related diseases like amyloidosis, acute pancreatitis, arthritis, atherosclerosis, cancer, heart disease, inflammatory bowel disease, myocardial infarction, senile dementia, retinal degeneration and senile cataract.
Use of an extract selected from the group consisting of the extracts having the HPLC and/or MS characteristics shown in Tables 1-24 for the preparation of a medicament for the treatment of any infectious disease.
Dependencies are inferred from the claim text.